Online summary
Correction to: Bruce A. Cohen and Victor M. Rivera. PRISMS – the story of a pivotal clinical trial series in multiple sclerosis. Curr Med Res Opin 2010; 26(4): 827-838, doi:10.1185/03007991003604018.
Correction to: Fliser D, Kleophas W, Dellanna F, et al. Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL study.
Correction to: Bruce A. Cohen and Victor M. Rivera. PRISMS – the story of a pivotal clinical trial series in multiple sclerosis. Curr Med Res Opin 2010; 26(4): 827-838, doi:10.1185/03007991003604018.
The authors have reported a minor correction that is required for of this article. The dosage details of the comparator for the EVIDENCE study were incorrect. The corrected table is provided below.
Table 1. Pivotal clinical studies of the efficacy and safety of interferon beta-1a.
Correction to: Fliser D, Kleophas W, Dellanna F, et al. Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL study.
In the original article published in Curr Med Res Opin 2010; 26(5):1083-1089, Dr. Frank Dellanna's name incorrectly appeared in the author list as ‘Dellana’. We are happy to correct this error.